Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-05-24
2011-05-24
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S237100, C530S350000
Reexamination Certificate
active
07947290
ABSTRACT:
A modified Staphylococcal enterotoxin B (SEB) having resistance to a protease and a reduced toxicity and a vaccine comprising said modified SEB are provided. A modified SEB which has an amino acid sequence as set forth in SEQ ID NO: 1 wherein each of the lysine at 97-position and the lysine at 98-position are substituted with any other amino acid, or a derivative thereof and a vaccine comprising said modified SEB or a derivative thereof.
REFERENCES:
patent: 6180097 (2001-01-01), Terman
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: 8-500328 (1996-01-01), None
patent: 1055429 (2000-11-01), None
patent: WO93/14634 (1993-08-01), None
patent: 96/36366 (1996-11-01), None
patent: WO96/36366 (1996-11-01), None
patent: 99/40935 (1999-08-01), None
Bowie et al (Science, 1990, 247:1306-1310).
Ellis (Chapter 29 of Vaccines, Plotkin, et al. (eds) WB Saunders, Philadelphia, 1998, especially p. 571, paragraph 2).
Ulrich et al In: R. ZChapter 31 Staphylococcal enterotoxin B and Related Pyrogenic Toxins R.G. In: R. Zatjchuk, Editor, Textbook of military medicine: Medical aspects of chemical and biological warfare Office of the Surgeon General, Department of Army, Washington, DC (1997), pp. 621-630.
Savransky et al 2003 Toxicology Pathology vol. 31 pp. 373-378.
Soos et al 1993 Neuroimmunol. vol. 43 (1-2) Abstract.
A.C. Papageorgiou et al., Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site, Structure 2(8):769-779, (1995) XP004587900.
Savransky et al., Toxicology Pathology, 31:373-378 (2003).
Soos et al., Neuroimmunol., 43(1-2):39 (1993).
Ulrich et al., Chapter 31 Staphylococcal enterotoxin B and Related Pyrogenic toxins, 621-630, (1997).
Bowie et al., Science, 247:1306-1310 (1990).
Plotkin et al., Chapter 29 of Vaccines, (eds.) WB Sauders, Philadephia, 1998, especially p. 571, paragraph 2.
Edano Toshiyuki
Koshi Tomoyuki
Nakashima Toshihiro
Nishihara Tsukasa
Ohkuchi Masao
Archie Nina A
Browdy and Neimark PLLC
Juridical Foundation, The Chemo-Sero-Therapeutic Research Instit
Kowa Company Ltd.
Zeman Robert A
LandOfFree
Protease-resistant modified SEB and vaccine containing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease-resistant modified SEB and vaccine containing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease-resistant modified SEB and vaccine containing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643469